Pacira Pharmaceuticals reported $31.35M in Cost of Sales for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Acelrx Pharmaceuticals ACRX:US $ 1.04M 0.26M
Adamas Pharmaceuticals ADMS:US 385K 212K
Aerie Pharmaceuticals AERI:US $ 6.7M 0.17M
Amerisourcebergen ABC:US $ 47620.79M 3443.54M
Antares Pharma ATRS:US $ 16.44M 2.61M
Astellas Pharma 4503:JP Y 58327M 9860M
Biodelivery Sciences International BDSI:US $ 5.82M 2.47M
Bristol Myers Squibb BMY:US $ 2503M 201M
Coherus Biosciences CHRS:US $ 7.51M 4.16M
Depomed DEPO:US $ 3.97M 2.81M
Endo International Ordinary Shares ENDP:US $ 305.29M 64.25M
Flexion Therapeutics FLXN:US $ 6.08M 277K
Heron Therapeutics HRTX:US $ 9.21M 0.18M
Horizon Pharma HZNP:US $ 100.37M 61.92M
Ironwood Pharmaceuticals IRWD:US $ 0M 0.9M
JAZZ PHA JAZZ:US $ 40.19M 9.97M
Johnson & Johnson JNJ:US $ 7036M 747M
Lannett LCI:US $ 85.91M 47.23M
Ligand Pharmaceuticals LGND:US $ 8.15M 3.59M
Nektar Therapeutics NKTR:US $ 5.76M 1.43M
Omeros OMER:US $ 263K 176K
Pacira Pharmaceuticals PCRX:US $ 31.35M 3.95M
Perrigo Ordinary Shares PRGO:US $ 641.6M 178.7M
Revance Therapeutics RVNC:US $ 4.22M 554K
Supernus Pharmaceuticals SUPN:US $ 14.95M 3.58M
Teva Pharmaceutical TEVA:IT 2.06B 309M
Xeris Pharmaceuticals Inc XERS:US $ 1.83M 1.58M
Zoetis ZTS:US $ 543M 55M